The researchers studied aquaporins and evaluated the association between AQP genotype and survival in severe sepsis. These proteins act as water channels through biological membranes of almost all cells in the human body and regulate multiple psychological pathways. Patients with a particular AQP5 promoter genotype were more than three times as likely to die from sepsis.
The study examined 154 German patients of Caucasian ethnicity with severe sepsis. The patients were genotyped for the AQP5 promoter polymorphism. Within the AQP5 promoter, researchers identified a genetic variant in some of the patients, which alters AQP5 expression. The study showed for the first time that this common genetic variation commonly influenced survival in severe sepsis. Survival rates were 57 percent for AA genotypes and 83 percent for combined AA/CC genotypes.
Read more on anesthesia:
–Study: Researchers Discover Accurate Predictor of Lumbar Plexus Depth in Children
-Study: Lethal Dose of Bupivacaine Higher for Rats 2 vs. 16 Weeks Old
–Society of Anesthesia and Sleep Medicine Encourages Anesthesiologists to Become ‘Perioperative Sleep Physicians’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
